Skip to main content

Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration

Publication ,  Conference
Wittmann Dayagi, T; Willis, L; Corriveau-Bourque, C; Cada, M; Rogers, ZR; Nakano, TA; Olson, TS; Wang, WC; Gillio, A; Coates, TD; Chawla, A ...
Published in: Blood
November 5, 2024

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

2691 / 2691

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wittmann Dayagi, T., Willis, L., Corriveau-Bourque, C., Cada, M., Rogers, Z. R., Nakano, T. A., … Dror, Y. (2024). Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration. In Blood (Vol. 144, pp. 2691–2691). American Society of Hematology. https://doi.org/10.1182/blood-2024-198302
Wittmann Dayagi, Talya, Laura Willis, Catherine Corriveau-Bourque, Michaela Cada, Zora R. Rogers, Taizo A. Nakano, Timothy S. Olson, et al. “Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration.” In Blood, 144:2691–2691. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-198302.
Wittmann Dayagi T, Willis L, Corriveau-Bourque C, Cada M, Rogers ZR, Nakano TA, et al. Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration. In: Blood. American Society of Hematology; 2024. p. 2691–2691.
Wittmann Dayagi, Talya, et al. “Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 2691–2691. Crossref, doi:10.1182/blood-2024-198302.
Wittmann Dayagi T, Willis L, Corriveau-Bourque C, Cada M, Rogers ZR, Nakano TA, Olson TS, Wang WC, Gillio A, Coates TD, Chawla A, Castillo P, Kurre P, Gamper C, Arnold SD, Joshi S, Geddis AE, Boklan J, Rothman JA, Huang JN, Kupfer GM, Glader B, Walkovich KJ, Thompson A, Hanna R, Williams DA, Shimamura A, Dror Y. Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration. Blood. American Society of Hematology; 2024. p. 2691–2691.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

2691 / 2691

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology